Clinical Study
7-Day Nonbismuth-Containing Concomitant Therapy Achieves a High Eradication Rate for Helicobacter pylori in Taiwan
Table 2
The major outcomes of 7-day concomitant therapy.
| | Outcome of 7-day concomitant therapy () |
| Eradication rate | | Intention to treat | 93.7% (299/319) | Per protocol | 96.4% (297/308) | Adverse events | 13.2% (42/319) | Compliance | 98.4% (314/319) |
|
|